253 related articles for article (PubMed ID: 30951603)
1. Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation.
Armenian SH; Xiao M; Berano Teh J; Lee B; Chang HA; Mascarenhas K; Lee S; Iukuridze A; Xie JJ; Scott JM; Jones LW; Lennie Wong F; Forman SJ; Nakamura R
J Natl Cancer Inst; 2019 Aug; 111(8):837-844. PubMed ID: 30951603
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.
Barba P; Piñana JL; Martino R; Valcárcel D; Amorós A; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
Biol Blood Marrow Transplant; 2010 Mar; 16(3):413-20. PubMed ID: 19922807
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Pretransplantation Prediction Models for Nonrelapse Mortality in Patients with Myelofibrosis Undergoing Allogeneic Stem Cell Transplantation.
Acosta-Medina AA; Baranwal A; Johnson IM; Kharfan-Dabaja MA; Murthy H; Palmer JM; Sproat L; Mangaonkar A; Shah MV; Hogan WJ; Litzow MR; Tefferi A; Alkhateeb HB
Transplant Cell Ther; 2023 Jun; 29(6):360.e1-360.e8. PubMed ID: 36773650
[TBL] [Abstract][Full Text] [Related]
4. Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.
Hoffmeister PA; Storer BE; Macris PC; Carpenter PA; Baker KS
Biol Blood Marrow Transplant; 2013 Jul; 19(7):1081-6. PubMed ID: 23623893
[TBL] [Abstract][Full Text] [Related]
5. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
Nakaya A; Mori T; Tanaka M; Tomita N; Nakaseko C; Yano S; Fujisawa S; Sakamaki H; Aotsuka N; Yokota A; Kanda Y; Sakura T; Nanya Y; Saitoh T; Kanamori H; Takahashi S; Okamoto S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1553-9. PubMed ID: 25034961
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
Wang CY; Ren HY; Qiu ZX; Wang Y; Cen XN; Wang LH; Wang MJ; Xu WL; Wang WS; Li Y; Dong YJ; Ou JP; Liang ZY; Liu W; Wang Q
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):659-63. PubMed ID: 23978015
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant.
Wood W; Deal A; Whitley J; Sharf A; Serody J; Gabriel D; Shea T
Pediatr Blood Cancer; 2011 Sep; 57(3):499-505. PubMed ID: 21384538
[TBL] [Abstract][Full Text] [Related]
8. Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation.
Friend BD; Broglie L; Logan BR; Chhabra S; Bupp C; Schiller G; Beitinjaneh A; Perez MAD; Guilcher GMT; Hashem H; Hildebrandt GC; Krem MM; Lazarus HM; Nishihori T; Nusrat R; Rotz SJ; Wirk B; Wieduwilt M; Pasquini M; Savani BN; Stadtmauer EA; Sorror ML; Thakar MS
Transplant Cell Ther; 2023 Feb; 29(2):123.e1-123.e10. PubMed ID: 36442769
[TBL] [Abstract][Full Text] [Related]
9. Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.
Barba P; Martino R; Pérez-Simón JA; Fernández-Avilés F; Castillo N; Piñana JL; López-Anglada L; Rovira M; Bosch F; Carreras E; Corral LL; Sierra J; Valcárcel D
Biol Blood Marrow Transplant; 2014 Jan; 20(1):66-72. PubMed ID: 24141006
[TBL] [Abstract][Full Text] [Related]
10. Social Vulnerability and Risk of Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation.
Bhandari R; Teh JB; He T; Nakamura R; Artz AS; Jankowska MM; Forman SJ; Wong FL; Armenian SH
J Natl Cancer Inst; 2022 Nov; 114(11):1484-1491. PubMed ID: 35980163
[TBL] [Abstract][Full Text] [Related]
11. Promising Outcome of Umbilical Cord Blood Transplantation in Patients with Multiple Comorbidities.
Adachi Y; Ukai S; Sagou K; Fukushima N; Ozeki K; Kohno A
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1455-1462. PubMed ID: 29476952
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Cell Transplantation-Specific Comorbidity Index Predicts Morbidity and Mortality in Autologous Stem Cell Transplantation.
Berro M; Arbelbide JA; Rivas MM; Basquiera AL; Ferini G; Vitriu A; Foncuberta C; Fernandez Escobar N; Requejo A; Milovic V; Yantorno S; Szelagoswki M; Martinez Rolon J; Bentolila G; Garcia JJ; Garcia P; Caeiro G; Castro M; Jaimovich G; Palmer S; Trucco JI; Bet LA; Shaw BE; Kusminsky GD
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1646-1650. PubMed ID: 28669923
[TBL] [Abstract][Full Text] [Related]
13. Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes.
DeFilipp Z; Troschel FM; Qualls DA; Li S; Kuklinski MW; Kempner ME; Hochberg E; Chen YB; El-Jawahri A; Fintelmann FJ
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1741-1747. PubMed ID: 29496561
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography-defined sarcopenia: prognostic predictor of nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a multicenter retrospective study.
Ando T; Fujisawa S; Teshigawara H; Matsumura A; Sakuma T; Suzuki T; Teranaka H; Ogusa E; Ishii Y; Miyashita K; Takahashi H; Nakajima Y; Miyazaki T; Hagihara M; Matsumoto K; Yamazaki E; Nakajima H
Int J Hematol; 2020 Jul; 112(1):46-56. PubMed ID: 32451786
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34
Barba P; Ratan R; Cho C; Ceberio I; Hilden P; Devlin SM; Maloy MA; Barker JN; Castro-Malaspina H; Jakubowski AA; Koehne G; Papadopoulos EB; Ponce DM; Sauter C; Tamari R; van den Brink MRM; Young JW; O'Reilly RJ; Giralt SA; Perales MA
Biol Blood Marrow Transplant; 2017 Jan; 23(1):67-74. PubMed ID: 27789361
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
Keller JW; Andreadis C; Damon LE; Kaplan LD; Martin TG; Wolf JL; Ai WZ; Venstrom JM; Smith CC; Gaensler KM; Hwang J; Olin RL
J Geriatr Oncol; 2014 Jul; 5(3):238-44. PubMed ID: 24894413
[TBL] [Abstract][Full Text] [Related]
17. Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States.
Hong S; Brazauskas R; Hebert KM; Ganguly S; Abdel-Azim H; Diaz MA; Beattie S; Ciurea SO; Szwajcer D; Badawy SM; Gratwohl AA; LeMaistre C; Aljurf MDSM; Olsson RF; Bhatt NS; Farhadfar N; Yared JA; Yoshimi A; Seo S; Gergis U; Beitinjaneh AM; Sharma A; Lazarus H; Law J; Ulrickson M; Hashem H; Schoemans H; Cerny J; Rizzieri D; Savani BN; Kamble RT; Shaw BE; Khera N; Wood WA; Hashmi S; Hahn T; Lee SJ; Rizzo JD; Majhail NS; Saber W
Cancer; 2021 Feb; 127(4):609-618. PubMed ID: 33085090
[TBL] [Abstract][Full Text] [Related]
18. Abnormal body composition is a predictor of adverse outcomes after autologous haematopoietic cell transplantation.
Armenian SH; Iukuridze A; Teh JB; Mascarenhas K; Herrera A; McCune JS; Zain JM; Mostoufi-Moab S; McCormack S; Slavin TP; Scott JM; Jones LW; Sun CL; Forman SJ; Wong FL; Nakamura R
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):962-972. PubMed ID: 32212263
[TBL] [Abstract][Full Text] [Related]
19. Identifying risk factors associated with worse outcomes in adolescents and young adults undergoing hematopoietic stem cell transplantation.
Friend BD; Tang K; Markovic D; Elashoff D; Moore TB; Schiller GJ
Pediatr Blood Cancer; 2019 Dec; 66(12):e27940. PubMed ID: 31429528
[TBL] [Abstract][Full Text] [Related]
20. Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Chang EK; Chanson D; Teh JB; Iukuridze A; Peng K; Forman SJ; Nakamura R; Wong FL; Cai L; Armenian SH
J Clin Oncol; 2021 Mar; 39(8):902-910. PubMed ID: 33417479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]